食管鳞癌切除标本中TIM-3表达的预后意义
本研究通过免疫组化检测183例未接受新辅助治疗、行食管切除术的食管鳞癌(ESCC)患者标本中TIM-3、PD-1及CD8+肿瘤浸润淋巴细胞(TIL)的表达,分析其与临床病理特征及预后的关系。结果发现TIM-3阳性与PD-1阳性及高CD8+ TIL密度显著相关,且为无复发生存(RFS)和总生存(OS)的独立危险因素;TIM-3+PD-1+CD8低表达组预后最差,TIM-3-PD-1-CD8高表达组预后最佳。
要点
- TIM-3阳性是ESCC切除术后RFS和OS的独立危险因素。
- TIM-3表达与PD-1阳性及高CD8+ TIL密度显著相关。
- 联合TIM-3、PD-1及CD8+ TIL密度可进一步区分预后亚组。
核心结论
- TIM-3阳性与PD-1阳性及高CD8+ TIL密度相关,是ESCC患者RFS和OS的独立危险因素。
- 联合TIM-3与PD-1表达或CD8+ TIL密度可将患者分为预后不同的亚组。
研究设计与样本
- 采用免疫组化检测TIM-3、PD-1及CD8+ TIL表达,分析其与临床病理特征及临床结局的关联。
主要发现
- PD-1阳性(P = .032)和高CD8+ TIL密度(P = .035)与TIM-3阳性表达显著相关。
- TIM-3阳性是无复发生存(RFS)的独立危险因素(P < .001)。
- TIM-3阳性是总生存(OS)的独立危险因素(P < .001)。
- 亚组分析显示TIM-3+PD-1+CD8低表达组RFS和OS最差,TIM-3-PD-1-CD8高表达组RFS和OS最佳(RFS:log-rank检验P < .001;OS:log-rank检验P < .001)。
临床怎么用
- 对手术切除的ESCC标本可检测TIM-3、PD-1及CD8+ TIL,辅助预后分层。
- TIM-3阳性且PD-1阳性、CD8+ TIL低的患者预后较差,可能需更密切随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) is a promising checkpoint. However, its features and prognostic value remain undetermined in esophageal squamous cell carcinoma (ESCC). This study evaluated the prognostic value of TIM-3 expression and its relationship with programmed cell death 1 (PD-1) and CD8+ tumor-infiltrating lymphocytes (TILs) in patients with surgically resected ESCC. METHODS: Expression levels of TIM-3, PD-1, and CD8+ TILs in ESCC were determined by immunohistochemistry. The association between clinicopathologic features or clinical outcomes and TIM-3 expression was analyzed. RESULTS: A total of 183 patients with ESCC who had undergone esophagectomy without implementation of neoadjuvant therapy at the Second Affiliated Hospital of Soochow University in Suzhou, China from January 2009 to December 2014 were included. PD-1 positivity (P = .032) and high CD8+ TIL density (P = .035) significantly correlated with positive TIM-3 expression. TIM-3 positivity was an independent risk factor for recurrence-free survival (RFS) (P < .001) and overall survival (OS) (P < .001). Subgroup analysis revealed that the TIM-3+PD-1+CD8 low group had the worst RFS and OS, whereas the TIM-3-PD-1-CD8 high group had the best RFS and OS (RFS: log-rank test P < .001; OS: log-rank test P < .001). CONCLUSIONS: Positive TIM-3 expression was associated with PD-1 positivity and high CD8+ TIL density and was an independent risk factor for RFS and OS in ESCC. Furthermore, the combination of TIM-3 and PD-1 expression or CD8+ TIL density could further stratify patients into different groups with distinct prognosis.
引用
- Zhao Y, Chen D, Wang W, et al. Significance of TIM-3 Expression in Resected Esophageal Squamous Cell Carcinoma. Ann Thorac Surg. 2020. PMID: 31987829. doi:10.1016/j.athoracsur.2019.12.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。